文献速递胸部病理细胞病理与分子病理

COVID-19肺部病理:意大利与纽约多机构尸检队列

COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City.
PubMed 文献 · Mod Pathol · 2020-09-02

该研究系统评估了来自美意3家机构68例尸检的肺组织,中位年龄73岁,87%见弥漫性肺泡损伤,84%至少局灶存在血小板和/或纤维蛋白微血栓。病毒检测阳性与透明膜存在相关,通常见于诊断后2周内、最长4周。

要点

  • COVID-19肺炎表现为气管支气管炎、DAD和血管损伤的异质性组合。
  • 微血栓常见(84%),大血管血栓见于42%病例。
  • 病毒检出与透明膜相关,提示活动性损伤区持续感染。

核心结论

  • COVID-19肺炎是包含气管支气管炎、DAD和血管损伤的异质性疾病,但三个中心特征一致。
  • 肺血管床常受累,表现为毛细血管微血栓、炎症及大血栓。
  • 持续活动性损伤区域的病毒感染导致持续且时间异质性的肺损伤。

研究设计与样本

  • 多机构尸检队列,来自意大利和纽约市3家重灾区机构,共68例尸检肺组织。
  • 系统评估气道、肺泡壁、气腔和血管等 compartments 的组织学特征。
  • 队列包括47例男性和21例女性,中位年龄73岁(范围30-96)。
  • 大多数患者有合并症,60%报告至少三种疾病。

主要发现

  • 气管支气管炎常见,独立于插管或重叠肺炎。
  • 弥漫性肺泡损伤(DAD)见于87%病例,晚期DAD较少且与病程较长相关。
  • 大血管血栓见于42%病例,血小板(CD61阳性)和/或纤维蛋白微血栓至少局灶存在于84%。
  • 超微结构显示小血管基底膜重复和显著内皮肿胀伴胞质空泡化。
  • 部分病例通过免疫组化、RNA原位杂交、肺病毒培养和电镜检测到病毒,见于气道上皮和2型肺泡上皮细胞。

关键数值与推荐

  • 免疫组化或原位检测及活病毒(肺培养阳性)与透明膜存在相关,通常见于初诊后2周内,最长4周。
  • DAD见于87%病例,晚期DAD较少且与病程较长相关。
  • 大血管血栓见于42%病例,微血栓至少局灶存在于84%。

临床怎么用

  • 病理诊断应关注气管支气管炎、DAD和血管损伤的组合特征。
  • 需重视微血栓和大血管血栓的评估,即使大体无明确血栓。
  • 病毒检测阳性结合透明膜提示活动性损伤期,可指导病程判断。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SARS-CoV-2, the etiologic agent of COVID-19, is a global pandemic with substantial mortality dominated by acute respiratory distress syndrome. We systematically evaluated lungs of 68 autopsies from 3 institutions in heavily hit areas (2 USA, 1 Italy). Detailed evaluation of several compartments (airways, alveolar walls, airspaces, and vasculature) was performed to determine the range of histologic features. The cohort consisted of 47 males and 21 females with a median age of 73 years (range 30-96). Co-morbidities were present in most patients with 60% reporting at least three conditions. Tracheobronchitis was frequently present, independent from intubation or superimposed pneumonia. Diffuse alveolar damage (DAD) was seen in 87% of cases. Later phases of DAD were less frequent and correlated with longer duration of disease. Large vessel thrombi were seen in 42% of cases but platelet (CD61 positive) and/or fibrin microthrombi were present at least focally in 84%. Ultrastructurally, small vessels showed basal membrane reduplication and significant endothelial swelling with cytoplasmic vacuolization. In a subset of cases, virus was detected using different tools (immunohistochemistry for SARS-CoV-2 viral spike protein, RNA in situ hybridization, lung viral culture, and electron microscopy). Virus was seen in airway epithelium and type 2 pneumocytes. IHC or in situ detection, as well as viable form (lung culture positive) was associated with the presence of hyaline membranes, usually within 2 weeks but up to 4 weeks after initial diagnosis. COVID-19 pneumonia is a heterogeneous disease (tracheobronchitis, DAD, and vascular injury), but with consistent features in three centers. The pulmonary vasculature, with capillary microthrombi and inflammation, as well as macrothrombi, is commonly involved. Viral infection in areas of ongoing active injury contributes to persistent and temporally heterogeneous lung damage.

来源:Mod Pathol,查看原文。版权归原作者所有。

引用

  1. Borczuk AC, Salvatore SP, Seshan SV, et al. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City. Mod Pathol. 2020. PMID: 32879413. doi:10.1038/s41379-020-00661-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。